Saint Petersburg Chemical Pharmaceutical University, St. Petersburg 197376, Russia.
St. Petersburg State Chemical and Pharmaceutical University of the Ministry of Health of the Russian Federation, St. Petersburg, Russia.
Int J Med Mushrooms. 2024;26(10):69-81. doi: 10.1615/IntJMedMushrooms.2024055012.
The present review highlights the chitin/chitosan as biopolymers that are promising for biomedical research development. Our goal was to assess the potential for practical use of these biopolymers and to summarize information on traditional and innovative technologies for their production and purification. The widespread occurrence of chitin and chitosan in nature as well as the unique chemical and biological properties of chitosan are reasons of growing interest in the use of the latter in several pharmaceutical fields. The main stages of chitin extraction and its further modification into chitosan are deproteinization, demineralization, deacetylation, and the main methods of chitosan purification are filtration, dialysis and reprecipitation. The profitability of the production of chitin/chitosan from crustaceans and edible mushrooms is approximately at the same level. The cost of mushroom products can be reduced by using agricultural or forestry waste as nutrient substrates. This makes the use of fungi as sources of chitin/chitosan in forested regions a rather promising issue.
本综述强调了壳聚糖/壳聚糖作为生物聚合物,在生物医学研究开发方面具有广阔的应用前景。我们的目标是评估这些生物聚合物的实际应用潜力,并总结有关其生产和纯化的传统和创新技术的信息。壳聚糖在自然界中的广泛存在以及壳聚糖独特的化学和生物学性质是人们对其在多个制药领域应用日益关注的原因。壳聚糖的提取及其进一步修饰为壳聚糖的主要阶段包括脱蛋白、脱矿质、脱乙酰化,壳聚糖的主要纯化方法是过滤、透析和再沉淀。从甲壳类动物和食用蘑菇中生产壳聚糖/壳聚糖的盈利水平大致相同。使用农业或林业废弃物作为营养基质可以降低蘑菇产品的成本。这使得在森林地区使用真菌作为壳聚糖/壳聚糖的来源成为一个非常有前景的问题。